Skip to content

Effect of atomized lidocaine inhalation on general anesthesia patients

Effect of atomized lidocaine inhalation on general anesthesia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065176
Enrollment
Unknown
Registered
2022-10-31
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients receiving general anesthesia

Interventions

L group:inhalat lidocaine
N group:inhalat saline

Sponsors

The First Hospital of Nanchang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) ASA I or II;(2) Aged from 18 to 60 years;(3) BMI<30(4) No difficult airway;(5) Plan to undergo elective surgery.

Exclusion criteria

Exclusion criteria: (1) Allergy history of amide local anesthetics;(2) Oral, ENT lesions or surgical history;(3) Severe cardiovascular and pulmonary diseases, liver and kidney insufficiency;(4) Patients with mental cognitive impairment or refusing to cooperate with follow-up;(6) Complicated with asthma, elevated blood eosinophils or other acute respiratory infections;(7) Participated in other clinical trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Changes of mean arterial pressure before and after intubation;

Secondary

MeasureTime frame
Average arterial pressure during extubation;Cough during extubation;Pharyngalgia 6 hours after operation;Pharyngalgia 24 hours after operation;The side effects and adverse reactions occurred;

Countries

China

Contacts

Public ContactHeguo Luo

The First Hospital of Nanchang

jxlhg@outlook.com+86 13807035516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026